Paul L.
- Country
- France
- Department
- site 007_Service Maladies infectieuses et tropicales
Research Overview
- Efficacy and Safety of AZD5148 for the Prevention of Recurrent Clostridioides difficile Infection in Adults: A Phase IIb, Randomized, Placebo-Controlled Study
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- A Phase 3b Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Antiretroviral-Naive Adults with HIV
Data & Insights
Has run more than one trial at 72 of 199 partner sites.
Specializations
Infectious Disease Management
The investigator specializes in treating complex prosthetic joint infections, particularly those caused by Staphylococcus aureus. Their research encompasses innovative approaches including phage therapy combined with conventional antibiotic treatments.
- Hip and knee joint infections
- Bacterial infections
- Antimicrobial therapy
HIV Treatment Innovation
The investigator focuses on advancing HIV-1 treatment protocols, exploring both novel drug combinations and simplified treatment regimens. Their work includes evaluation of various antiretroviral therapies and treatment optimization strategies.
- Antiretroviral therapy
- Viral suppression
- Treatment simplification
Vaccine Development and Immunology
The investigator conducts research in vaccine immunogenicity and preventive medicine, including studies on pneumococcal vaccines and yellow fever immunization. Their work extends to COVID-19 prevention strategies and novel antibody treatments.
- Vaccine safety assessment
- Immune response evaluation
- Preventive medicine
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.